kabutan

PhoenixBio, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 31%

Fri Nov 14, 2025 3:40 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE Growth] announced its financial results after the market closed on November 14th (15:40). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) turned into a profit of 16 million yen (compared to a loss of 123 million yen in the same period last year).

However, the full-year forecast for consolidated ordinary profit has decreased 31.0%, from the previous forecast of 168 million yen to 116 million yen (compared to a loss of 155 million yen in the previous period).

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the October to March period (second half) is expected to turn into a profit of 100 million yen (compared to a loss of 32 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated ordinary loss improved to a deficit of 4 million yen (compared to a loss of 148 million yen in the same period last year). The operating profit/loss margin drastically improved from -30.4% in the same period last year to -5.1%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 881 -5 45 27 7.5 104.7 Nov 14, 2023 J-GAAP
Apr - Sep, 2024 788 -98 -123 -124 -30.9 ー Nov 14, 2024 J-GAAP
Apr - Sep, 2025 756 5 16 12 3.0 13.8 Nov 14, 2025 J-GAAP
YoY -4.1% － － － －

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance 895 76 77 73 17.9 0 May 15, 2025 J-GAAP
Apr - Sep, 2025 Results 756 5 16 12 3.0 0 Nov 14, 2025 J-GAAP
Revision Rate -15.5% -93.4% -79.2% -83.6% -83.1%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 1,759 167 168 161 39.6 0 May 15, 2025 J-GAAP
Mar, 2026 New 1,640 109 116 110 27.0 0 Nov 14, 2025 J-GAAP
Revision Rate -6.8% -34.7% -31.0% -31.7% -31.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 753 -44 -32 -324 -80.3 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 884 104 100 98 24.1 0 Nov 14, 2025 J-GAAP
YoY +17.4% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 1,715 11 43 26 7.0 0 May 15, 2024 J-GAAP
Mar, 2025 1,541 -142 -155 -448 -111.0 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance 1,640 109 116 110 27.0 0 Nov 14, 2025 J-GAAP
YoY +6.4% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 339 -103 -148 -147 -36.6 -30.4 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 355 -55 -23 -26 -6.5 -15.5 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 398 11 -9 -298 -73.8 2.8 May 15, 2025 J-GAAP
Apr - Jun, 2025 400 23 20 19 4.7 5.8 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 356 -18 -4 -7 -1.8 -5.1 Nov 14, 2025 J-GAAP
YoY +5.0% +82.5% +97.3% +95.2% +95.2%

Related Articles